Advisors Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Buy |
39,093
+2,068
| +6% | +$680K | 0.19% | 112 |
|
|
2025
Q4 | $13M | Buy |
37,025
+1,480
| +4% | +$500K | 0.22% | 84 |
|
|
2025
Q3 | $11.5M | Buy |
35,545
+5,143
| +17% | +$1.6M | 0.19% | 105 |
|
|
2025
Q2 | $11.8M | Buy |
30,402
+6,603
| +28% | +$2.66M | 0.21% | 98 |
|
|
2025
Q1 | $10.4M | Buy |
23,799
+10,887
| +84% | +$4.37M | 0.19% | 113 |
|
|
2024
Q4 | $4.76M | Buy |
12,912
+4,535
| +54% | +$1.9M | 0.09% | 300 |
|
|
2024
Q3 | $4.36M | Buy |
8,377
+3,054
| +57% | +$1.63M | 0.08% | 317 |
|
|
2024
Q2 | $2.88M | Buy |
5,323
+810
| +18% | +$428K | 0.06% | 435 |
|
|
2024
Q1 | $2.34M | Buy |
4,513
+505
| +13% | +$251K | 0.05% | 501 |
|
|
2023
Q4 | $1.89M | Sell |
4,008
-354
| -8% | -$164K | 0.04% | 549 |
|
|
2023
Q3 | $1.9M | Sell |
4,362
-126
| -3% | -$57.2K | 0.04% | 523 |
|
|
2023
Q2 | $1.99M | Buy |
4,488
+111
| +3% | +$51.2K | 0.04% | 509 |
|
|
2023
Q1 | $2.01M | Sell |
4,377
-266
| -6% | -$127K | 0.04% | 522 |
|
|
2022
Q4 | $2.38M | Buy |
4,643
+2,196
| +90% | +$1.12M | 0.05% | 447 |
|
|
2022
Q3 | $1.11M | Sell |
2,447
-32
| -1% | -$15.3K | 0.02% | 687 |
|
|
2022
Q2 | $1.2M | Sell |
2,479
-2,417
| -49% | -$1.2M | 0.02% | 696 |
|
|
2022
Q1 | $2.4M | Sell |
4,896
-1,834
| -27% | -$838K | 0.04% | 526 |
|
|
2021
Q4 | $3.12M | Sell |
6,730
-1,470
| -18% | -$618K | 0.04% | 455 |
|
|
2021
Q3 | $3.06M | Sell |
8,200
-538
| -6% | -$204K | 0.05% | 438 |
|
|
2021
Q2 | $3.34M | Sell |
8,738
-1,592
| -15% | -$608K | 0.05% | 402 |
|
|
2021
Q1 | $3.71M | Sell |
10,330
-2,170
| -17% | -$698K | 0.06% | 344 |
|
|
2020
Q4 | $4.01M | Sell |
12,500
-908
| -7% | -$279K | 0.07% | 293 |
|
|
2020
Q3 | $3.6M | Buy |
13,408
+1,233
| +10% | +$332K | 0.07% | 277 |
|
|
2020
Q2 | $3.2M | Buy |
12,175
+4,700
| +63% | +$1.25M | 0.06% | 315 |
|
|
2020
Q1 | $1.7M | Sell |
7,475
-3,135
| -30% | -$854K | 0.04% | 457 |
|
|
2019
Q4 | $3.21M | Buy |
10,610
+69
| +0.7% | +$19K | 0.06% | 380 |
|
|
2019
Q3 | $2.53M | Sell |
10,541
-1,831
| -15% | -$502K | 0.05% | 447 |
|
|
2019
Q2 | $3.49M | Sell |
12,372
-448
| -3% | -$122K | 0.06% | 356 |
|
|
2019
Q1 | $3.68M | Buy |
12,820
+547
| +4% | +$158K | 0.07% | 344 |
|
|
2018
Q4 | $3.22M | Buy |
12,273
+3,202
| +35% | +$880K | 0.06% | 340 |
|
|
2018
Q3 | $2.49M | Sell |
9,071
-815
| -8% | -$212K | 0.04% | 524 |
|
|
2018
Q2 | $2.35M | Sell |
9,886
-674
| -6% | -$156K | 0.04% | 549 |
|
|
2018
Q1 | $2.49M | Sell |
10,560
-2,203
| -17% | -$518K | 0.04% | 538 |
|
|
2017
Q4 | $2.87M | Sell |
12,763
-788
| -6% | -$168K | 0.05% | 504 |
|
|
2017
Q3 | $2.57M | Sell |
13,551
-469
| -3% | -$89.3K | 0.04% | 531 |
|
|
2017
Q2 | $2.64M | Sell |
14,020
-2,033
| -13% | -$365K | 0.04% | 524 |
|
|
2017
Q1 | $2.65M | Sell |
16,053
-5,299
| -25% | -$843K | 0.04% | 528 |
|
|
2016
Q4 | $3.07M | Buy |
21,352
+990
| +5% | +$133K | 0.05% | 488 |
|
|
2016
Q3 | $2.55M | Sell |
20,362
-5,867
| -22% | -$758K | 0.04% | 548 |
|
|
2016
Q2 | $3.44M | Sell |
26,229
-4,414
| -14% | -$604K | 0.06% | 476 |
|
|
2016
Q1 | $4.26M | Buy |
30,643
+132
| +0.4% | +$17.6K | 0.07% | 393 |
|
|
2015
Q4 | $4.25M | Sell |
30,511
-2,317
| -7% | -$319K | 0.07% | 415 |
|
|
2015
Q3 | $4.6M | Sell |
32,828
-2,858
| -8% | -$430K | 0.07% | 376 |
|
|
2015
Q2 | $5.86M | Buy |
35,686
+6,548
| +22% | +$1.05M | 0.08% | 336 |
|
|
2015
Q1 | $4.5M | Buy |
29,138
+12,433
| +74% | +$1.77M | 0.06% | 409 |
|
|
2014
Q4 | $2.1M | Buy |
16,705
+3,997
| +31% | +$494K | 0.03% | 621 |
|
|
2014
Q3 | $1.52M | Buy |
12,708
+1,775
| +16% | +$204K | 0.02% | 699 |
|
|
2014
Q2 | $1.18M | Sell |
10,933
-144
| -1% | -$14.8K | 0.02% | 782 |
|
|
2014
Q1 | $1.1M | Buy |
11,077
+3,092
| +39% | +$280K | 0.02% | 731 |
|
|
2013
Q4 | $738K | Buy |
7,985
+3,885
| +95% | +$345K | 0.01% | 854 |
|
|
2013
Q3 | $343K | Buy |
4,100
+543
| +15% | +$46.5K | 0.01% | 1004 |
|
|
2013
Q2 | $291K | Buy |
+3,557
| New | +$266K | 0.01% | 999 |
|
Other funds holding ELV
VCM
VPM
Advisors Asset Management's ELV Position: Q1 2026 in Review
Advisors Asset Management increased its Elevance Health (ELV) stake by 5.6% in Q1 2026, buying an estimated $680K and bringing the position to 39,093 shares worth $11.4M. The position accounts for 0.19% of the portfolio, ranked #112.
Advisors Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Advisors Asset Management held 39,093 shares of Elevance Health worth $11.4M as of Q1 2026.
- Advisors Asset Management bought 2,068 Elevance Health shares in Q1 2026, an estimated $680K.
- Elevance Health made up 0.19% of Advisors Asset Management's portfolio in Q1 2026, its #112 holding.
- Advisors Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's Elevance Health position peaked at $13M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.